Cover Image
市場調查報告書

抗感染疾病藥的全球市場:抗生劑·抗病毒藥物·抗真菌藥·其他 (驅蟲劑·抗原蟲藥)

Anti-Infective Drugs Global Market Report 2018

出版商 The Business Research Company 商品編碼 531330
出版日期 內容資訊 英文 125 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
抗感染疾病藥的全球市場:抗生劑·抗病毒藥物·抗真菌藥·其他 (驅蟲劑·抗原蟲藥) Anti-Infective Drugs Global Market Report 2018
出版日期: 2018年02月01日 內容資訊: 英文 125 Pages
簡介

本報告提供全球抗感染疾病藥的市場調查,提供市場定義和概要,市場的各種影響因素分析,各藥物部門·各地各國趨勢與市場規模的變化與預測,並彙整與宏觀經濟因素·醫療保健市場全體·各種產業指標的比較,競爭環境,企業簡介等資料。

第1章 市場特徵

第2章 市場規模·成長率

  • 市場成長:迄今的過程
    • 成長推進因素
    • 阻礙成長要素
  • 市場成長:預測
    • 成長推進因素
    • 阻礙成長要素

第3章 大環境分析

第4章 客戶資訊

第5章 抗感染疾病藥市場分析:各種類

  • 全球市場的實際成果:各種類
    • 抗生劑
    • 抗病毒藥物
    • 抗真菌藥
    • 其他 (驅蟲劑·抗原蟲藥)
  • 全球市場的變化與預測:各種類
  • 市場趨勢·策略

第6章 抗感染疾病藥市場分析:各地各國分析

  • 全球市場的實際成果:各地區
  • 全球市場的變化與預測:各地區
  • 市場實際成果:各國
  • 市場變化與預測:各國
  • 全球醫藥品市場實際成果:部門·各地區
  • 全球醫藥品市場實際成果:部門·各國

第7章 宏觀經濟因素與市場比較

  • 市場規模的佔 GDP的百分比
  • 平均每個人的平均支出額

第8章 宏觀經濟因素與市場比較:各國

  • 市場規模的佔 GDP的百分比:各國
  • 平均每個人的平均支出額:各國

第9章 產業指標與市場比較

  • 全球藥劑師數:各國
  • 市場收益 vs 藥劑師數:各國
  • 全球醫藥品公司數:各國
  • 市場收益 vs 醫藥品公司數:各國
  • 全球對R&D/產品開發的平均支出額:各國
  • 市場收益 vs 對R&D/產品開發的平均支出額:各國
  • 全球非專利&品牌銷售額的比例:各國
  • 市場收益 vs 非專利&品牌銷售額的比例:各國
  • HIV的患病人數:各國
  • 全球一般開業醫生數:各國
  • 市場收益 vs 一般開業醫生數:各國

第10章 亞太地區市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 中國
  • 印度
  • 日本
  • 澳洲

第11章 西歐市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙

第12章 東歐市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 俄羅斯

第13章 北美市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 美國

第14章 南美市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 巴西

第15章 中東市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類

第16章 非洲市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類

第17章 競爭環境

  • 企業簡介
  • Pfizer Inc.
  • Glaxosmithkline
  • F. Hoffmann-La Roche Ltd
  • Bristol-Myers Squibb Company
  • Sanofi

第18章 主要M&A:抗感染疾病藥市場

第19章 市場背景:醫藥品市場

第20章 醫藥品產業的Financial Margins

第21章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Anti-Infective Drugs Market Global Report 2018 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global anti-infective drugs market.

Where is the largest and fastest growing market for the anti-infective drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-infective drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider Healthcare market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The anti-infective drugs market section of the report gives context. It compares the anti-infective drugs market with other segments of the Healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Anti-Infective Drugs Indicators Comparison.

Scope:

Markets Covered: Antivirals; Antibiotics; Antifungals; Others (Antihelmethic, Antiprotozoal)

Companies Mentioned: Gilead,Merck & Co,GlaxosmithKline,Bristol-Myers Squibb Company,Johnson & Johnson

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Anti-Infective Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Reasons to Purchase:

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

1. Anti-Infective Drugs Market Characteristics

2. Anti-Infective Drugs Market Size And Growth

  • 2.1. Historic Market Growth, Value ($ Billion) and Volume (Million Units)
    • 2.1.1. Drivers Of The Market
    • 2.1.2. Restraints On The Market
  • 2.2. Forecast Market Growth, Value ($ Billion)
    • 2.2.1. Drivers Of The Market
    • 2.2.2. Restraints On The Market

3. Anti-Infective Drugs Trends And Strategies

4. Pestle Analysis

  • 4.1. Political
  • 4.2. Economic
  • 4.3. Social
  • 4.4. Technological
  • 4.5. Legal
  • 4.6. Environmental

5. Anti-Infective Drugs Market Customer Information

6. Anti-Infective Drugs Market Regional And Country Analysis

  • 6.1. Global Anti-Infective Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
  • 6.2. Global Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, By Region
  • 6.3. Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Region
  • 6.4. Global Anti-Infective Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
  • 6.5. Global Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, By Country
  • 6.6. Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country

7. Anti-Infective Drugs Market Segmentation

  • 7.1. Global Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

  • 7.2. Global Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

8. Anti-Infective Drugs Market Segments

  • 8.1.Antivirals

a) Market Characteristics

b) Market Trends & Strategies

c) Global Antivirals Market, 2017, By Segment, Value ($ Billion)

  • 8.2.Antibiotics

a) Market Characteristics

b) Market Trends & Strategies

c) Global Antibiotics Market, 2017, By Segment, Value ($ Billion)

  • 8.3.Antifungals

a) Market Characteristics

b) Market Trends & Strategies

c) Global Antifungals Market, 2017, By Segment, Value ($ Billion)

  • 8.4.Others (Antihelmethic, Antiprotozoal)

a) Market Characteristics

b) Market Trends & Strategies

c) Global Others (Antihelmethic, Antiprotozoal) Market, 2017, By Segment, Value ($ Billion)

9. Global Anti-Infective Drugs Market Comparison With Macro Economic Factors

  • 9.1. Anti-Infective Drugs Market Size, Percentage Of GDP, Global
  • 9.2. Per Capita Average Anti-Infective Drugs Expenditure, Global

10. Anti-Infective Drugs Market Comparison With Macro Economic Factors Across Countries

  • 10.1. Anti-Infective Drugs Market Size, Percentage Of GDP, By Country
  • 10.2. Per Capita Average Anti-Infective Drugs Expenditure, By Country

11. Anti-Infective Drugs Market Comparison With Industry Metrics

  • 11.1. Global Number Of Pharmacists, 2017, By Country
  • 11.2. Global Infectious Diseases Market Revenue Versus Number Of Pharmacists, 2017, By Country
  • 11.3. Global Number Of Pharma Enterprises, 2017, By Country
  • 11.4. Global Infectious Diseases Market Revenue Versus Number Of Pharma Enterprises, 2017, By Country
  • 11.5. Global Average Spending On R&D/Product Development, 2017, By Country
  • 11.6. Global Infectious Diseases Market Revenue Versus Average Spending On R&D/Product Development, 2017, By Country
  • 11.7. Global Generic & Branded Sales Proportion By Country (Value), 2017, By Country
  • 11.8. Global Infectious Diseases Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2017, By Country
  • 11.9. Prevalent Cases Of Hiv, 2014, By Country
  • 11.10. Global Number Of General Practitioners 2017, By Country
  • 11.11. Global Infectious Diseases Market Revenue Versus Number Of General Practitioners, 2017, By Country

12. Asia-Pacific Anti-Infective Drugs Market

    • 12.1.1. Asia-Pacific Anti-Infective Drugs Market Overview
    • 12.1.2. Asia-Pacific Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.1.3. Asia-Pacific Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.1.4. Asia-Pacific Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 12.1.5. Asia-Pacific Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.2. Asia-Pacific Anti-Infective Drugs Market: Country Analysis
  • 12.3. China Anti-Infective Drugs Market
    • 12.3.1. China Anti-Infective Drugs Market Overview
    • 12.3.2. China Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.3.3. China Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.3.4. China Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 12.3.5. China Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.4. India Anti-Infective Drugs Market
    • 12.4.1. India Anti-Infective Drugs Market Overview
    • 12.4.2. India Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.4.3. India Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.4.4. India Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 12.4.5. India Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.5. Japan Anti-Infective Drugs Market
    • 12.5.1. Japan Anti-Infective Drugs Market Overview
    • 12.5.2. Japan Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.5.3. Japan Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.5.4. Japan Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 12.5.5. Japan Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.6. Australia Anti-Infective Drugs Market
    • 12.6.1. Australia Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.6.2. Australia Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.6.3. Australia Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 12.6.4. Australia Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

13. Western Europe Anti-Infective Drugs Market

    • 13.1.1. Western Europe Anti-Infective Drugs Market Overview
    • 13.1.2. Western Europe Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.1.3. Western Europe Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.1.4. Western Europe Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 13.1.5. Western Europe Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.2. Western Europe Anti-Infective Drugs Market: Country Analysis
  • 13.3. UK Anti-Infective Drugs Market
    • 13.3.1. UK Anti-Infective Drugs Market Overview
    • 13.3.2. UK Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.3.3. UK Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.3.4. UK Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 13.3.5. UK Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.4. Germany Anti-Infective Drugs Market
    • 13.4.1. Germany Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.4.2. Germany Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.4.3. Germany Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 13.4.4. Germany Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.5 France Anti-Infective Drugs Market
    • 13.5.1 France Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.5.2 France Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.5.3. France Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 13.5.4. France Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.6. Italy Anti-Infective Drugs Market
    • 13.6.1. Italy Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.6.2. Italy Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.6.3. Italy Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 13.6.4. Italy Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.7. Spain Anti-Infective Drugs Market
    • 13.7.1. Spain Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.7.2. Spain Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.7.3. Spain Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 13.7.4. Spain Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Anti-Infective Drugs Market

    • 14.1.1. Eastern Europe Anti-Infective Drugs Market Overview
    • 14.1.2. Eastern Europe Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 14.1.3. Eastern Europe Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 14.1.4. Eastern Europe Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 14.1.5. Eastern Europe Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 14.2. Eastern Europe Anti-Infective Drugs Market: Country Analysis
  • 14.3. Russia Anti-Infective Drugs Market
    • 14.3.1. Russia Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 14.3.2. Russia Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 14.3.3. Russia Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 14.3.4. Russia Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

15. North America Anti-Infective Drugs Market

    • 15.1.1. North America Anti-Infective Drugs Market Overview
    • 15.1.2. North America Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 15.1.3. North America Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 15.1.4. North America Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 15.1.5. North America Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 15.2. North America Anti-Infective Drugs Market: Country Analysis
  • 15.3. USA Anti-Infective Drugs Market
    • 15.3.1. USA Anti-Infective Drugs Market Overview
    • 15.3.2. USA Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 15.3.3. USA Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 15.3.4. USA Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 15.3.5. USA Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

16. South America Anti-Infective Drugs Market

    • 16.1.1. South America Anti-Infective Drugs Market Overview
    • 16.1.2. South America Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 16.1.3. South America Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 16.1.4. South America Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 16.1.5. South America Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 16.2. South America Anti-Infective Drugs Market: Country Analysis
  • 16.3. Brazil Anti-Infective Drugs Market
    • 16.3.1. Brazil Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 16.3.2. Brazil Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 16.3.3. Brazil Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 16.3.4. Brazil Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

17. Middle East Anti-Infective Drugs Market

    • 17.1.1. Middle East Anti-Infective Drugs Market Overview
    • 17.1.2. Middle East Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 17.1.3. Middle East Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 17.1.4. Middle East Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 17.1.5. Middle East Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

18. Africa Anti-Infective Drugs Market

    • 18.1.1. Africa Anti-Infective Drugs Market Overview
    • 18.1.2. Africa Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 18.1.3. Africa Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 18.1.4. Africa Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antivirals

Antibiotics

Antifungals

Others (Antihelmethic, Antiprotozoal)

    • 18.1.5. Africa Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

19. Anti-Infective Drugs Market Competitive Landscape

  • 19.1. Company Profiles
  • 19.2. Gilead
    • 19.2.1. Overview
    • 19.2.2. Products And Services
    • 19.2.3. Strategy
    • 19.2.4. Financial Performance
  • 19.3. Merck & Co
    • 19.3.1. Overview
    • 19.3.2. Products And Services
    • 19.3.3. Strategy
    • 19.3.4. Financial Performance
  • 19.4. GlaxosmithKline
    • 19.4.1. Overview
    • 19.4.2. Products And Services
    • 19.4.3. Strategy
    • 19.4.4. Financial Performance
  • 19.5. Bristol-Myers Squibb Company
    • 19.5.1. Overview
    • 19.5.2. Products And Services
    • 19.5.3. Strategy
    • 19.5.4. Financial Performance
  • 19.6. Johnson & Johnson
    • 19.6.1. Overview
    • 19.6.2. Products And Services
    • 19.6.3. Strategy
    • 19.6.4. Financial Performance

20. Key Mergers And Acquisitions In The Anti-Infective Drugs Market

21. Market Background: Anti-Infective Drugs Market

    • 21.1.1. Anti-Infective Drugs Market Characteristics
    • 21.1.2. Anti-Infective Drugs Market Historic Growth, Value ($ Billion)
      • 21.1.2.1. Drivers Of The Market
      • 21.1.2.2. Restraints Of The Market
    • 21.1.3. Anti-Infective Drugs Market Forecast Growth, Value ($ Billion)
      • 21.1.3.1. Drivers Of The Market
      • 21.1.3.2. Restraints Of The Market
    • 21.1.4. Anti-Infective Drugs Trends And Strategies
  • 21.2. Anti-Infective Drugs Market Regional And Country Analysis
    • 21.2.1. Global Anti-Infective Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
    • 21.2.2. Global Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, By Region
    • 21.2.3. Anti-Infective Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
    • 21.2.4. Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, By Country
    • 21.2.5. Anti-Infective Drugs Market, Growth And Market Share Comparison, By Segment
    • 21.2.6. Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country And Segment
  • 21.3. Global Anti-Infective Drugs Market Comparison With Macro Economic Factors
    • 21.3.1. Anti-Infective Drugs Market Size, Percentage Of GDP, Global
    • 21.3.2. Per Capita Average Anti-Infective Drugs Expenditure, Global
  • 21.4. Anti-Infective Drugs Market Comparison With Macro Economic Factors Across Countries
    • 21.4.1. Anti-Infective Drugs Market Size, Percentage Of GDP, By Country
    • 21.4.2. Per Capita Average Anti-Infective Drugs Expenditure, By Country
  • 21.5. Key Mergers And Acquisitions In The Anti-Infective Drugs Market

22. Appendix

  • 22.1. NAICS Definitions Of Industry Covered In This Report
  • 22.2. Abbreviations
  • 22.3. Currencies
  • 22.4. Research Inquiries
  • 22.5. The Business Research Company
  • 22.6. Copyright And Disclaimer
Back to Top